might have a role in cardiovascular and renal morbidity and mortality in hypertensive patients with type II diabetes. In a cross-sectional study, Kamgar and co-workers investigated the ratio of ...

In contrast to cardiorenal syndrome ... it should be acknowledged that there is overlap between these two syndromes; diabetes and hypertension can initiate both cardiac and renal pathology.

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...

They also examined if the presence of heart and kidney disease (cardiorenal disease) impacted these connections. Their analysis found: Only 6% of people with type 2 diabetes had all five risk factors ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for ...

Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...

In older adults with diabetes, GLP-1 receptor agonists were ... Both drug classes improve glycemic control, reduce weight, and offer cardiorenal benefits, which may contribute to better overall ...

Study: Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes ... while also promoting beneficial cardiorenal effects and reducing the risk of ...

Medscape Diabetes & Endocrinology, July 18, 2024 Episode 3: SGLT2 Inhibitors: A Future in Cardiorenal Metabolic Syndrome Join Drs Nihar Desai and Jay Udell as they discuss the role of SGLT2 ...

AstraZeneca has extended its cardiorenal pipeline with a $1.3 billion acquisition of CinCor Pharma, adding a late-stage blood pressure-lowering drug. The $26-per-share upfront deal focuses on ...